abagovomab 49
abciximab 43
abituzumab 33
abrilumab 31
actoxumab 32
adalimumab 22
aducanumab 19
afasevikumab 25
alacizumab_pegol 16
alemtuzumab 44
alirocumab 26
amatuximab 58
andecaliximab 37
anifrolumab 33
anrukinzumab 26
aprutumab 21
aprutumab_ixadotin 21
arcitumomab 29
ascrinvacumab 24
atezolizumab 16
atinumab 24
avelumab 21
basiliximab 53
bavituximab 52
begelomab 42
benralizumab 40
bevacizumab_beta 28
bezlotoxumab 32
bimagrumab 32
bleselumab 33
blinatumomab 55
blosozumab 37
bococizumab 33
brazikumab 23
brentuximab_vedotin 47
briakinumab 22
brodalumab 32
brolucizumab 32
brontictuzumab 37
burosumab 33
cabiralizumab 38
camrelizumab 17
canakinumab 30
cantuzumab_ravtansin 61
carlumab 28
carotuximab 35
cergutuzumab_amunaleukin2 40
cergutuzumab_amunaleukin 40
certolizumab_pegol 28
cetiximab 57
citatuzumab_bogatox 32
cixutumumab 45
clivatuzumab_tetraxetan 39
codrituzumab 41
conatumumab 27
concizumab 35
crenezumab 26
crizanlizumab 37
crotedumab 26
dacetuzumab 27
daclizumab 29
dalotuzumab 54
dapirolizumab_pegol 31
daratumumab 19
dectrekumab 15
demcizumab 41
denosumab 12
depatuxizumab 39
depatuxizumab_mafodotin 39
dezamizumab 34
dinutuximab 49
diridavumab 40
domagrozumab 20
drozitumab 29
duligotuzumab 21
durvalumab 19
dusigitumab 38
efalizumab 38
efungumab 37
eldelumab 25
elezanumab 37
elgemtumab 15
elotuzumab 24
emactuzumab 35
emapalumab 32
emibetuzumab 33
enavatuzumab 30
enfortumab_vedotin 19
enoblituzumab 23
enokizumab 36
enoticumab 27
ensituximab 49
eptinezumab 21
erenumab 30
etaracizumab 19
etrolizumab 25
evinacumab 26
evolocumab 33
farletuzumab 20
fasinumab 34
fezakinumab 38
fibatuzumab 32
ficlatuzumab 38
firivumab 44
flanvotumab 32
fletikumab 42
foralumab 22
foravirumab 19
fremanezumab 36
fresolimumab 31
fulranumab 25
futuximab 44
galcanezumab 29
ganitumab 44
gantenerumab 18
gemetuzumab 46
gemtuzumab2 40
gemtuzumab 42
gevokizumab 38
girentuximab 38
glembatumumab 38
glembatumumab_vedotin 38
guselkumab 32
ibalizumab 38
ibritumomab 54
icrucumab 21
idarucizumab 54
ifabotuzumab 32
imalumab 19
imgatuzumab 35
inclacumab 27
indatuximab_ravtansin 46
indusatumab 33
inebilizumab 36
intetumumab 24
iodine_girentuximab 35
ipilimumab 12
iratumumab 29
isatuximab 48
itolizumab 31
ixekizumab 44
labetuzumab_govitecan 30
lambrolizumab 38
lampalizumab 33
lanadelumab 21
landogrozumab 22
laprituximab 37
lebrikizumab 48
lendalizumab 37
lenzilumab 30
lifastuzumab_vedotin 28
ligelizumab 36
lilotomab 51
lirilumab 38
lodelcizumab 32
lokivetmab 30
lorvotuzumab_mertansin 31
lucatumumab 35
lumretuzumab 31
lupartumab 20
lutikizumab 23
margetuximab 46
milatuzumab 52
mirvetuximab 51
mirvetuximab_soravtansin 51
modotuximab 58
mogamulizumab 38
monalizumab 35
motavizumab 48
moxetumomab_pasudotox 35
namilumab 39
naratuximab 45
naratuximab_emtansin 45
narnatumab 26
navicixizumab2 35
navicixizumab 42
navivumab 47
necitumumab 29
nemolizumab 39
nesvacumab 21
nivolumab 22
obiltoxaximab 33
obinutuzumab 43
ocaratuzumab 37
ofatumumab 25
olaratumab 36
olokizumab 30
omalizumab 24
onartuzumab 27
ontuxizumab 43
opicinumab 19
orticumab 18
otelixizumab 44
oxelumab 15
ozanezumab 46
pamrevlumab 15
panobacumab 33
parsatuzumab 33
pasotuxizumab 23
pateclizumab 24
patritumab 39
pembrolizumab 38
perakizumab 27
pidilizumab 32
pinatuzumab_vedotin 22
plozalizumab 34
pogalizumab 36
polatuzumab_vedotin 27
ponezumab 48
prezalumab 18
pritoxaximab 58
quilizumab 24
racotumomab 45
radretumab 20
ralpancizumab 35
ramucirumab 18
ranevetmab 37
ranibizumab 28
refanezumab 34
remtolumab 21
rilotumumab 39
rinucumab 37
risankizumab 46
rituximab 38
rivabazumab 28
robatumumab 22
roledumab 37
romosozumab 35
rontalizumab 29
rosmantuzumab 39
rozanolixizumab 30
sacituzumab 41
sacituzumab_govitecan 41
samalizumab 36
sapelizumab 35
sarilumab 20
secukinumab 26
seribantumab 20
setoxaximab 58
sifalimumab 31
siltuximab 39
simtuzumab 40
sirukumab 20
solanezumab 29
solitomab 42
stamulumab 35
suptavumab 33
suvizumab 31
tabalumab 33
tadocizumab 29
tamtuvetmab 41
tanezumab 37
tarextumab 16
tavolixizumab 32
telisotuzumab 43
teplizumab 31
tesidolumab 44
tezepelumab 37
tigatuzumab 20
tildrakizumab 31
timolumab 22
tisotumab 18
tosatoxumab 48
tositumomab 51
tralokinumab 47
trastuzumab 25
tregalizumab 29
trevogrumab 19
ublituximab 45
urelumab 40
ustekinumab 36
utomilumab 42
vadastuximab 40
vadastuximab_talirin 40
vandortuzumab_vedotin 25
vantictumab 33
vanucizumab2 28
vanucizumab 51
varlilumab 20
vatelizumab 39
vedolizumab 45
veltuzumab 34
vesencumab 15
vorsetuzumab 37
vorsetuzumab_mafodotin 37
vunakizumab 52
xentuzumab 23
zatuximab 58
